The leading donor-derived cell-free DNA (dd-cfDNA) test for identifying kidney injury. Used by more than 30,000 patients at over 150 U.S. transplant centers
The leading donor-derived cell-free DNA (dd-cfDNA) test for identifying kidney injury. Used by more than 30,000 patients at over 150 U.S. transplant centers
CareDx is continuing to innovate with new products like HistoMap and UroMap and post-market approval studies